LifeStance Health Expects Q3 Revenue of $290M-$310M Vs. $301.898M Est.
Portfolio Pulse from Benzinga Newsdesk
LifeStance Health has raised its full-year 2024 revenue guidance to $1.2 billion-$1.242 billion, with improved Center Margin and Adjusted EBITDA. For Q3 2024, the company expects revenue of $290 million-$310 million, which is in line with estimates.
August 08, 2024 | 10:11 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
LifeStance Health has raised its full-year 2024 revenue guidance to $1.2 billion-$1.242 billion, with improved Center Margin and Adjusted EBITDA. For Q3 2024, the company expects revenue of $290 million-$310 million, which is in line with estimates.
The raised guidance for 2024 and the expected Q3 revenue being in line with estimates are positive indicators for LifeStance Health. This suggests strong performance and potential growth, likely leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100